Stay updated on Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.6.5 was added to the page’s revision history and Revision: v3.6.4 was removed, updating the version information reflected on the page.SummaryDifference0.0%

- Check9 days agoChange DetectedThe Study Documents section now omits several PDFs and references (CSR synopsis, SAP, CSP, IPD Sharing information, and related disclosures). This change removes access to key study documentation and data-sharing commitments, altering how users can review the trial's protocol and results materials.SummaryDifference17%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe page's revision tag was updated to v3.6.4 from v3.6.3, indicating a minor metadata update to the study record. This does not change any study details or user-facing content presented on the page.SummaryDifference0.0%

- Check31 days agoChange DetectedJuly 2026 update timestamps were added to the study record and older May–June entries were removed from the update history, reflecting routine administrative maintenance of the page.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page's revision label changed from v3.6.0 to v3.6.3, indicating a small patch-level update to the page metadata.SummaryDifference0.0%

- Check60 days agoChange DetectedRecruitment status has been updated to No longer looking for participants, and results have been posted. The page now includes new navigation sections and expanded location and timeline details, plus added study documents (Study Protocol and SAP).SummaryDifference3%

Stay in the know with updates to Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.